What's the law.

Modern pharmaceuticals are one of the greatest developments in modern living. Because drugs are potentially harmful, they are regulated by the Food and Drug Administration (FDA). The FDA prescribes rigid procedures for the approval of new drugs. Most of the approval procedures depend upon honest reporting by the manufacturers. Sometimes drugs have dangerous side effects that were ignored or concealed by the manufacturers. When these drugs are sold, persons injured by these side effects have a claim for compensation against the manufacturer.

Record Fen-phen settlement

Fen-phen (a.k.a. phen-phen, fenfluramine, redux) was a widely prescribed diet drug that was pulled from the market in 1997 when it was realized that it caused numerous heart and circulatory injuries, including pulmonary hypertension, heart valve degeneration, and other illnesses. The firm represented over 200 fen-phen users who were injured by the drug. A substantial settlement was obtained from the manufacturer. Hundreds of the firms’s clients were recently awarded settlements for potential effects of the diet drug "Fen-phen." The class settlement, one of the largest of its kind, affected many hundreds of clients who, on advice of the firm, had opted out of a national class action that would have returned only $75 per person. Said one client, “This was a swift, fair settlement of my claim, one that avoided years of litigation. My hat is off to the attorneys who negotiated it.”